News

AddToAny

Google+ Facebook Twitter Twitter

Natural killer cells vs. macrophages

New knowledge about naturally acquired malaria immunity may improve vaccines, it is claimed.

Researchers from the University of Copenhagen have found an important difference between naturally acquired immunity and immunity following vaccination.

Professor Lars Hviid said: “The antibodies which the body produces when you have been infected with malaria look different from those produced by the body when you have been vaccinated. And that probably means that our immune system has a more efficient response when we have been naturally infected than when we are vaccinated against malaria.”

He added that with malaria the body launches what are called “natural killer cells”.

“Our study points to a new strategy for developing even better malaria vaccines in the future. Because, now, we know how the body mobilises the defence with natural killer cells, and we can imitate that with vaccines,” he said.

The team behind the work hopes that a future malaria vaccine will be developed that will be able to utilise natural killer cells instead of the macrophages that the current vaccines use.

go.nature.com/3wNsySk

Image credit |Shutterstock

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top